Optain

New York, United States · Founded 2023

Headquarters
New York, New York
Employees
11–50
Founded
2023
Business Model
B2B
Last Round
Series ASep 2025
Rounds
2

About

Optain is an AI-enabled retinal screening company that combines a portable camera with advanced algorithms to detect over 140 eye and systemic conditions non-invasively at the point of care. The platform screens for diabetic retinopathy, glaucoma, macular degeneration, and cardiovascular risk in under 60 seconds with over 90% accuracy. Founded in 2023 and backed by Aegis Ventures and Northwell Health, Optain targets clinical and primary care settings globally.

Summary

Optain is an Artificial Intelligence company based in New York, United States, founded in 2023. Its most recent funding was a Series A round in Sep 2025. Investors include Insight Partners, Aegis Ventures and Northwell Health.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries ASep 2025

Sign up to see all 2 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Optain on Indexed.vc
<a href="https://indexed.vc/companies/optain"><img src="https://indexed.vc/api/badge/company/optain" alt="Optain on Indexed.vc" width="260" height="76" /></a>